Mutations that augment Wnt ligand activity, e.g., in the LGR5 ligand RSPO, are mutually exclusive to APC mutations, illustrating two alternative pathways for oncogenic Wnt signaling in colorectal cancer (109). The gene discussed is RSPO1; the disease is colorectal cancer.